Health Catalyst Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $11.09
- Today's High:
- $11.49
- Open Price:
- $11.49
- 52W Low:
- $6.4
- 52W High:
- $15.87
- Prev. Close:
- $11.38
- Volume:
- 326837
Company Statistics
- Market Cap.:
- $667.61 million
- Book Value:
- 6.895
- Revenue TTM:
- $284.60 million
- Operating Margin TTM:
- -37.88%
- Gross Profit TTM:
- $135.56 million
- Profit Margin:
- -51.76%
- Return on Assets TTM:
- -8.78%
- Return on Equity TTM:
- -34.3%
Company Profile
Health Catalyst Inc had its IPO on 2019-07-25 under the ticker symbol HCAT.
The company operates in the Healthcare sector and Health Information Services industry. Health Catalyst Inc has a staff strength of 1,200 employees.
Stock update
Shares of Health Catalyst Inc opened at $11.49 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $11.09 - $11.49, and closed at $11.11.
This is a -2.37% slip from the previous day's closing price.
A total volume of 326,837 shares were traded at the close of the day’s session.
In the last one week, shares of Health Catalyst Inc have slipped by -5.2%.
Health Catalyst Inc's Key Ratios
Health Catalyst Inc has a market cap of $667.61 million, indicating a price to book ratio of 1.3552 and a price to sales ratio of 2.2542.
In the last 12-months Health Catalyst Inc’s revenue was $284.60 million with a gross profit of $135.56 million and an EBITDA of $-70345000. The EBITDA ratio measures Health Catalyst Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Health Catalyst Inc’s operating margin was -37.88% while its return on assets stood at -8.78% with a return of equity of -34.3%.
In Q2, Health Catalyst Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 3.7%.
Health Catalyst Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-2.75 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Health Catalyst Inc’s profitability.
Health Catalyst Inc stock is trading at a EV to sales ratio of 1.7083 and a EV to EBITDA ratio of -4.7587. Its price to sales ratio in the trailing 12-months stood at 2.2542.
Health Catalyst Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $722.90 million
- Total Liabilities
- $86.76 million
- Operating Cash Flow
- $-7415000.00
- Capital Expenditure
- $4.80 million
- Dividend Payout Ratio
- 0%
Health Catalyst Inc ended 2024 with $722.90 million in total assets and $0 in total liabilities. Its intangible assets were valued at $722.90 million while shareholder equity stood at $389.87 million.
Health Catalyst Inc ended 2024 with $0 in deferred long-term liabilities, $86.76 million in other current liabilities, 1454897000.00 in common stock, $-1064826000.00 in retained earnings and $185.98 million in goodwill. Its cash balance stood at $115.69 million and cash and short-term investments were $343.83 million. The company’s total short-term debt was $3,468,000 while long-term debt stood at $227.28 million.
Health Catalyst Inc’s total current assets stands at $410.95 million while long-term investments were $0 and short-term investments were $228.14 million. Its net receivables were $52.38 million compared to accounts payable of $7.97 million and inventory worth $0.
In 2024, Health Catalyst Inc's operating cash flow was $-7415000.00 while its capital expenditure stood at $4.80 million.
Comparatively, Health Catalyst Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $11.11
- 52-Week High
- $15.87
- 52-Week Low
- $6.4
- Analyst Target Price
- $15.08
Health Catalyst Inc stock is currently trading at $11.11 per share. It touched a 52-week high of $15.87 and a 52-week low of $15.87. Analysts tracking the stock have a 12-month average target price of $15.08.
Its 50-day moving average was $12.4 and 200-day moving average was $12.1 The short ratio stood at 2.65 indicating a short percent outstanding of 0%.
Around 247.9% of the company’s stock are held by insiders while 9005.2% are held by institutions.
Frequently Asked Questions About Health Catalyst Inc
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.